Anticancer activity of TTAC-0001, a fully human anti-vascular endothelial growth factor receptor 2 (VEGFR-2/KDR) monoclonal antibody, is associated with inhibition of tumor angiogenesis

Vascular endothelial growth factor (VEGF) and its receptors are considered the primary cause of tumor-induced angiogenesis. Specifically, VEGFR-2/kinase insert domain receptor (KDR) is part of the major signaling pathway that plays a significant role in tumor angiogenesis, which is associated with t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:MAbs
Main Authors: Kim, Dong Geon, Jin, Younggeon, Jin, Juyoun, Yang, Heekyoung, Joo, Kyeung Min, Lee, Weon Sup, Shim, Sang Ryeol, Kim, Sung-Woo, Yoo, Jinsang, Lee, Sang Hoon, Yoo, Jin-San, Nam, Do-Hyun
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2015
Assuntos:
Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4966428/
https://ncbi.nlm.nih.gov/pubmed/26325365
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2015.1086854
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados